I specialize in treating blood cancers such as leukemia and lymphoma utilizing chemotherapy and radiation, targeted therapy, immunotherapy, and cellular therapy. I focus particularly on cellular therapies such as bone marrow transplantation and modified lymphocytes (CAR-T and CAR-NK). My research focuses on making these products safer to administer and more widely available.
My research focuses on utilizing biomarkers to predict outcomes of novel cellular therapies. In the short term, this will allow for better patient care and safer delivery of these novel treatments. In the long run, it will allow us to determine who benefits and who doesn't from these, and more specifically, what to do with patients who are unlikely to benefit.
T-cell lymphoma; Non-Hodgkin's lymphoma; Acute leukemia; Bone marrow transplant; Cellular therapies; CAR-T cells